1. Home
  2. FVCB vs VYGR Comparison

FVCB vs VYGR Comparison

Compare FVCB & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FVCB
  • VYGR
  • Stock Information
  • Founded
  • FVCB 2007
  • VYGR 2013
  • Country
  • FVCB United States
  • VYGR United States
  • Employees
  • FVCB N/A
  • VYGR N/A
  • Industry
  • FVCB Major Banks
  • VYGR Biotechnology: Pharmaceutical Preparations
  • Sector
  • FVCB Finance
  • VYGR Health Care
  • Exchange
  • FVCB Nasdaq
  • VYGR Nasdaq
  • Market Cap
  • FVCB 204.0M
  • VYGR 172.6M
  • IPO Year
  • FVCB N/A
  • VYGR 2015
  • Fundamental
  • Price
  • FVCB $12.83
  • VYGR $3.73
  • Analyst Decision
  • FVCB Buy
  • VYGR Strong Buy
  • Analyst Count
  • FVCB 1
  • VYGR 7
  • Target Price
  • FVCB $16.00
  • VYGR $14.50
  • AVG Volume (30 Days)
  • FVCB 35.8K
  • VYGR 866.3K
  • Earning Date
  • FVCB 07-22-2025
  • VYGR 08-06-2025
  • Dividend Yield
  • FVCB 1.87%
  • VYGR N/A
  • EPS Growth
  • FVCB 359.39
  • VYGR N/A
  • EPS
  • FVCB 1.11
  • VYGR N/A
  • Revenue
  • FVCB $62,780,000.00
  • VYGR $42,580,000.00
  • Revenue This Year
  • FVCB $12.99
  • VYGR N/A
  • Revenue Next Year
  • FVCB $7.26
  • VYGR $78.89
  • P/E Ratio
  • FVCB $11.57
  • VYGR N/A
  • Revenue Growth
  • FVCB 40.73
  • VYGR N/A
  • 52 Week Low
  • FVCB $9.49
  • VYGR $2.65
  • 52 Week High
  • FVCB $14.50
  • VYGR $8.28
  • Technical
  • Relative Strength Index (RSI)
  • FVCB 51.59
  • VYGR 61.89
  • Support Level
  • FVCB $12.25
  • VYGR $2.99
  • Resistance Level
  • FVCB $13.39
  • VYGR $3.57
  • Average True Range (ATR)
  • FVCB 0.37
  • VYGR 0.31
  • MACD
  • FVCB -0.01
  • VYGR 0.05
  • Stochastic Oscillator
  • FVCB 50.88
  • VYGR 84.16

About FVCB FVCBankcorp Inc.

FVCBankcorp Inc is a registered bank holding company. It operates through the sole subsidiary, FVCbank which is a community-oriented, locally-owned, and managed commercial bank. It offers commercial banking services to small and medium-sized businesses, professionals, non-profit organizations and associations, and investors. It also provides retail banking services to accommodate the individual needs of both corporate customers as well as the communities it serves. The bank provides other facilities such as online banking, mobile banking, remote deposit service, and lending products, among others. Its primary source of revenue is the net interest income.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

Share on Social Networks: